The Council and the Parliament have reached a deal on new rules to make the EU’s pharmaceutical sector fairer and more ...
Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients 80% CR and 90% Composite ...
The data showed encouraging anti-tumor responses and a manageable safety profile for pumitamig plus chemotherapy in first-line and second-line treatment setting. The data will be presented at the 2025 ...
The study makes clear that regulators expect human oversight to remain central to pharmaceutical quality assurance. Human operators must participate at key control points and retain authority to ...
GSK and Ideaya first linked up in 2020 to advance novel therapies for solid tumors. It is unclear why the pharma terminated ...
"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's offering.
Doximity shows record engagement, AI adoption, stronger revenue, high margins, $890M cash, and no debt with upside potential.
Commvault Systems is positioned as a leading cyber resiliency and data backup provider. Click here to read why CVLT stock is ...
Data integrity is the backbone of every clinical trial, ensuring that research truly benefits patients and advances medical science. When information is accurate, complete, and transparent, doctors ...
Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results